Original Query: ALL
Previous Study | Return to List | Next Study

Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00016224
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : June 18, 2013
National Cancer Institute (NCI)
Information provided by:
Memorial Sloan Kettering Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2004
  Study Completion Date : March 2004